Halozyme Therapeutics, Inc. (HALO)

70.43 -0.78 (-1.10%) USD  |  NASDAQ  |  Jan 20, 16:00
70.43 0.00 (0.00%) After-Hours: 20:00
More

Halozyme Therapeutics Excess Tax Benefit from Stock Compensation (Quarterly)

Excess Tax Benefit from Stock Compensation (Quarterly) Chart

View Excess Tax Benefit from Stock Compensation (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Excess Tax Benefit from Stock Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years

View Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks

View Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks
Start Trial
Johnson & Johnson --
Merck & Co., Inc. --
AIM ImmunoTech, Inc. --
Stryker Corp. --
Skye Bioscience, Inc. --